94 related articles for article (PubMed ID: 17447651)
1. Evaluation of a new ELISA for the detection of specific IgG to the Epstein-Barr nuclear antigen 1 (EBNA-1).
Schenk BI; Michel PO; Enders G; Thilo N; Radtke M; Oker-Blom C; Franke D
Clin Lab; 2007; 53(3-4):151-5. PubMed ID: 17447651
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of three ELISA techniques and an indirect immunofluorescence assay for the serological diagnosis of Epstein-Barr virus infection.
Debyser Z; Reynders M; Goubau P; Desmyter J
Clin Diagn Virol; 1997 May; 8(1):71-81. PubMed ID: 9248660
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
[TBL] [Abstract][Full Text] [Related]
4. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
[TBL] [Abstract][Full Text] [Related]
5. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.
Yamazaki M; Kitamura R; Kusano S; Eda H; Sato S; Okawa-Takatsuji M; Aotsuka S; Yanagi K
Clin Exp Immunol; 2005 Mar; 139(3):558-68. PubMed ID: 15730403
[TBL] [Abstract][Full Text] [Related]
6. Analytical performance evaluation of the Elecsys Epstein-Barr virus immunoassay panel.
Schulte-Spechtel U; Berth M; Lauseker-Hao Y; Meyer-Schlinkmann K; Bohnert M; Jochum S; Schuhmann K
Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115443. PubMed ID: 34304105
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies.
Bruu AL; Hjetland R; Holter E; Mortensen L; Natås O; Petterson W; Skar AG; Skarpaas T; Tjade T; Asjø B
Clin Diagn Lab Immunol; 2000 May; 7(3):451-6. PubMed ID: 10799460
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Performance and Comparative Evaluation of the Architect, Liaison, and Platelia Epstein-Barr Virus Antibody Assays.
Park Y; Park BG; Ha J; Kim HS
Ann Lab Med; 2018 Sep; 38(5):458-465. PubMed ID: 29797817
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method.
Gärtner BC; Hess RD; Bandt D; Kruse A; Rethwilm A; Roemer K; Mueller-Lantzsch N
Clin Diagn Lab Immunol; 2003 Jan; 10(1):78-82. PubMed ID: 12522043
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic evaluation of a new panel of assays for Epstein-Barr virus serology.
Radtke M; Gärtner B; Franke D
Clin Lab; 2007; 53(3-4):149-50. PubMed ID: 17447650
[No Abstract] [Full Text] [Related]
11. [Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status].
De Ory F; Guisasola ME; Sanz JC; García-Bermejo I
Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):618-20. PubMed ID: 22854635
[TBL] [Abstract][Full Text] [Related]
12. A systematic study of Epstein-Barr virus serologic assays following acute infection.
Rea TD; Ashley RL; Russo JE; Buchwald DS
Am J Clin Pathol; 2002 Jan; 117(1):156-61. PubMed ID: 11789721
[TBL] [Abstract][Full Text] [Related]
13. Anti-EBNA-1 (carboxy-half) IgG antibodies as a seroepidemiological marker for Epstein-Barr virus infection.
Nebel-Schickel H; Hinderer W; Saavedra C; Schmutzler R; Horn J; Vornhagen R; Sonneborn HH
Beitr Infusionsther Transfusionsmed; 1994; 32():134-7. PubMed ID: 9422107
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections.
de Ory F; Guisasola ME; Sanz JC; García-Bermejo I
Clin Vaccine Immunol; 2011 Mar; 18(3):444-8. PubMed ID: 21191077
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the new ARCHITECT EBV assays considering different testing algorithms.
Sickinger E; Berth M; Vockel A; Braun HB; Oer M; Buenning C
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):310-6. PubMed ID: 24809858
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two automated instruments for Epstein-Barr virus serology in a large adult hospital and implementation of an Epstein-Barr virus nuclear antigen-based testing algorithm.
Al Sidairi H; Binkhamis K; Jackson C; Roberts C; Heinstein C; MacDonald J; Needle R; Hatchette TF; LeBlanc JJ
J Med Microbiol; 2017 Nov; 66(11):1628-1634. PubMed ID: 29034860
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status.
Klutts JS; Liao RS; Dunne WM; Gronowski AM
J Clin Microbiol; 2004 Nov; 42(11):4996-5000. PubMed ID: 15528686
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus serostatus: no difference despite aberrant patterns in athletes and control group.
Pottgiesser T; Wolfarth B; Schumacher YO; Bauer G
Med Sci Sports Exerc; 2006 Oct; 38(10):1782-91. PubMed ID: 17019300
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a multiplex fluorescent microsphere immunoassay for the determination of epstein-barr virus serologic status.
Martins TB; Litwin CM; Hill HR
Am J Clin Pathol; 2008 Jan; 129(1):34-41. PubMed ID: 18089487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]